2018
Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy
Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, Mundle W, Rey E, Rabi DM, Daskalopoulou SS, Nerenberg KA, Canada H. Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Canadian Journal Of Cardiology 2018, 34: 526-531. PMID: 29731014, DOI: 10.1016/j.cjca.2018.02.021.Peer-Reviewed Original ResearchConceptsManagement of hypertensionAntihypertensive therapySevere hypertensionBlood pressure targetsNewborn adverse outcomesManagement of womenTreatment of hypertensionGynaecologists of CanadaSociety of ObstetriciansAntihypertensive medicationsNonsevere hypertensionPressure targetsNewborn complicationsAdverse outcomesCanadian recommendationsHypertensionPregnancyCanada guidelinesTherapyGuidelinesSpecific evidenceManagementMedicationsComplicationsObstetricians
2015
Drug-induced fulminant hepatic failure in pregnancy
Firoz T, Webber D, Rowe H. Drug-induced fulminant hepatic failure in pregnancy. Obstetric Medicine 2015, 8: 190-192. PMID: 27512479, PMCID: PMC4935052, DOI: 10.1177/1753495x15598909.Peer-Reviewed Original ResearchFulminant hepatic failureHepatic failureLiver failureGestational ageLiver diseaseDrug-induced liver injuryAbnormal liver functionWeeks gestational agePregnant patientsElevated liverLiver biopsyLiver injuryLiver functionSignificant causePregnancyPatientsMedicationsLabetalolMethyldopaDiseaseFailureCauseJaundiceBiopsyHepatotoxicity